Checking how well transplanted islet cells work in chronic pancreatitis
Part of Digestive system clinical trials.
This study looks at how well a treatment works after islet cell transplantation done for people with long-term (chronic) pancreatitis. It may help doctors better understand graft (transplant) function and how to choose the best approach and follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic pancreatitis, and you are scheduled for TP alone or TP with islet transplantation (TP-AIT)
- You are 18 years old or older
- You can and are willing to return for required follow-up visits at Baylor
- If you are getting TP-AIT, your pancreas disease must not be too advanced, based on chart and test review
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests whether adding your own special cells (mesenchymal stromal cells) at the same time as a TP-IAT transplant can improve diabetes outcomes. It may help people who are already planning TP-IAT, but it is only for certain age, diabetes, and health criteria.
This trial tests a two-part surgery: removing the pancreas and then putting the patient’s own insulin-making cells back into the body to help control long-term pancreatitis pain. It is aimed at adults with severe, long-lasting pain who have not improved with medicines or procedures.
This study collects health information and samples over time from people with chronic pancreatitis to learn more about the disease and improve care. It may include endoscopic procedures, which use a thin tube to look at the pancreas.
This study looks at outcomes after a procedure called TPIAT (total pancreatectomy with islet auto-transplantation), which aims to improve insulin function and blood-sugar control. It may help doctors better understand how people do over time after the procedure.
This study checks how well transplanted islet cells are working over time and monitors long-term safety. If you previously received an islet transplant and are still using medicine to prevent rejection, you may be followed again.
This study follows people over the long term after their islet transplant fully stops working. It aims to learn what happens after complete graft loss and monitor health outcomes over time.
Hear when a new Chronic Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.